BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 24, 1999
View Archived Issues
Synthetic Blood, Nitric Oxide Solutions team up for development of NO delivery technology
Read More
Ipratropium bromide may improve sleep, nocturnal oxygen in COPD patients
Read More
SangStat and Abbott sign collaborative agreement for SangCya
Read More
FDA clears phase III trial of Cerus's FFP pathogen inactivation system
Read More
Phase I trial of Biojector 2000 to deliver malaria DNA vaccine
Read More
Risperidone may reduce risk of relapse in schizophrenia
Read More
MediGene discovers target gene for DCM therapy
Read More
Ligand: Q1 1999 highlights
Read More
Betathine trial progressing well
Read More
Celltech: interim report October 1998-March 1999
Read More
OSI and Pfizer enter license agreement to develop psoriasis treatment
Read More
Vivus signs registration and marketing agreement in Japan for Muse
Read More
Compounds for promoting hair growth or regrowth disclosed by Shiseido
Read More
Early studies indicate efficacy of thalidomide in Crohn's disease
Read More
Compounds in development at Shionogi reverse oncogene-induced cell transformation
Read More
Calcium channel antagonists from Ajinomoto especially useful in IBS
Read More
Yoshitomi reports potent and selective tryptase inhibitors with oral activity
Read More
News from DDW: rhIL-10 in treatment of Crohn's disease
Read More
The NO-coupled NSAID HCT-1026 does not cause duodenal injury in rat model
Read More
Phogen receives further funding from Cantab and Marie Curie Cancer Care for VP22 technology
Read More
Cholera vaccine CVD103HgR-pDA60 is an excellent candidate for human studies
Read More
Isolex cell selection system receives approval from Health Canada
Read More
MMP inhibitor MMI-270 tested in cancer patients in combination with 5-FU/folinic acid
Read More
FDA advisory panel review of Levulan to be rescheduled
Read More
Tibetan herbal compound is effective in treating symptoms of IBS
Read More
Xenova: Q1 1999 highlights
Read More
Merck researchers describe L-783281, a novel antidiabetic agent of fungal origin
Read More